Self-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs

dc.authorid0000-0002-9452-9276
dc.authorid0000-0003-0428-2511
dc.contributor.authorBasım, ?Pelin
dc.contributor.authorArğun, Derya
dc.contributor.authorÖzdenkaya, Yaşar
dc.date.accessioned2021-01-27T10:04:03Z
dc.date.available2021-01-27T10:04:03Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground To investigate medication adherence (MA) to Levothyroxine in differentiated thyroid cancer survivors and analyze the related factors for nonadherence. Methods The Medication Adherence Report Scale (MARS), Hospital Anxiety and Depression Scale (HAD), Brief Illness Perception Questionnaire (B-IPQ), and Beliefs about Medicines Questionnaire (BMQ) were used to assess MA. Results Nonadherence was reported in 77 of 197 patients (39.1%). Socioeconomic status and education levels were found to be significantly related to MA. The HAD scores, all items of B-IPQ, and BMQ were associated with MA and showed a correlation with the MARS scores. The primary predictors of MA were greater confidence in treatment modality (odds ratio [OR]: 0.48, 95% confidence interval (CI): 0.37-0.63) and greater belief that the medication had minimal risk of harm (OR: 3.35, 95% CI: 1.50-7.49). Conclusions Special attention should be paid to educational programs for differentiated thyroid carcinoma patients concerning the effectiveness and low risk of harm of medication in order to improve MA.
dc.identifier.citationBasım, ?P., Arğun, D. ve Özdenkaya, Y. (2021). Self-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 43(2), 428-437. https://dx.doi.org/10.1002/hed.26488
dc.identifier.doi10.1002/hed.26488
dc.identifier.endpage437
dc.identifier.issn1043-3074
dc.identifier.issn1097-0347
dc.identifier.issue2
dc.identifier.scopusqualityQ1
dc.identifier.startpage428
dc.identifier.urihttps://dx.doi.org/10.1002/hed.26488
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6412
dc.identifier.volume43
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofHead and Neck-Journal for the Sciences and Specialties of the Head and Necken_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDifferentiated Thyroid Cancer
dc.subjectLevothyroxine
dc.subjectMedication Adherence
dc.subjectMedication Beliefs
dc.titleSelf-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Basim-Pelin-2021.pdf
Boyut:
627.24 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: